Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Bayley

Showing results (1-10 of 120) with videos related to

Pageof 12
Sort By:
Current Urology Reports|May 21, 2003
Radiotherapy for t3 prostate cancerAndrew Bayley, Mary K Gospodarowicz
Journal of Medical Imaging and Radiation Sciences|April 7, 2020
Cannabis and Radiation Therapy: A Scoping Review of Human Clinical TrialsTara Rosewall, Carina Feuz, Andrew Bayley
The Canadian Journal of Urology|April 18, 2001
Progression of prostate cancer despite undetectable serum prostate specific antigenEdward Chow, Michael McLean, Bruce Patterson, et al.
Journal of Medical Imaging and Radiation Oncology|October 7, 2016
'Compromise position' image alignment to accommodate independent motion of multiple clinical target volumes during radiotherapy: A high risk prostate cancer exampleTara Rosewall, Jing Yan, Hamideh Alasti, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 11, 2002
A dose-volume histogram analysis of the seminal vesicles in men treated with conformal radiotherapy to 'prostate alone'Christopher Parker, Tara Haycocks, Andrew Bayley, et al.
International Journal of Radiation Oncology, Biology, Physics|March 15, 2008
The effect of changing technique, dose, and PTV margin on therapeutic ratio during prostate radiotherapyShao Hui Huang, Charles Catton, John Jezioranski, et al.
International Journal of Radiation Oncology, Biology, Physics|December 27, 2005
Spinal cord planning risk volumes for intensity-modulated radiation therapy of head-and-neck cancerStephen L Breen, Tim Craig, Andrew Bayley, et al.
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|September 18, 2010
The effect of registration surrogate and patient factors on the interobserver variability of electronic portal image guidance during prostate radiotherapyVickie Kong, Gina Lockwood, Jing Yan, et al.
The Urologic Clinics of North America|December 19, 2003
Recurrent prostate cancer following external beam radiotherapy: follow-up strategies and managementCharles Catton, Michael Milosevic, Padraig Warde, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 7, 2010
The relationship between external beam radiotherapy dose and chronic urinary dysfunction--a methodological critiqueTara Rosewall, Charles Catton, Geoffrey Currie, et al.
Pageof 12

Showing results (1-10 of 120) with videos related to

Sort By:
Pageof 12
Current Urology Reports|May 21, 2003
Radiotherapy for t3 prostate cancerAndrew Bayley, Mary K Gospodarowicz
Journal of Medical Imaging and Radiation Sciences|April 7, 2020
Cannabis and Radiation Therapy: A Scoping Review of Human Clinical TrialsTara Rosewall, Carina Feuz, Andrew Bayley
The Canadian Journal of Urology|April 18, 2001
Progression of prostate cancer despite undetectable serum prostate specific antigenEdward Chow, Michael McLean, Bruce Patterson, et al.
Journal of Medical Imaging and Radiation Oncology|October 7, 2016
'Compromise position' image alignment to accommodate independent motion of multiple clinical target volumes during radiotherapy: A high risk prostate cancer exampleTara Rosewall, Jing Yan, Hamideh Alasti, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 11, 2002
A dose-volume histogram analysis of the seminal vesicles in men treated with conformal radiotherapy to 'prostate alone'Christopher Parker, Tara Haycocks, Andrew Bayley, et al.
International Journal of Radiation Oncology, Biology, Physics|March 15, 2008
The effect of changing technique, dose, and PTV margin on therapeutic ratio during prostate radiotherapyShao Hui Huang, Charles Catton, John Jezioranski, et al.
International Journal of Radiation Oncology, Biology, Physics|December 27, 2005
Spinal cord planning risk volumes for intensity-modulated radiation therapy of head-and-neck cancerStephen L Breen, Tim Craig, Andrew Bayley, et al.
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|September 18, 2010
The effect of registration surrogate and patient factors on the interobserver variability of electronic portal image guidance during prostate radiotherapyVickie Kong, Gina Lockwood, Jing Yan, et al.
The Urologic Clinics of North America|December 19, 2003
Recurrent prostate cancer following external beam radiotherapy: follow-up strategies and managementCharles Catton, Michael Milosevic, Padraig Warde, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 7, 2010
The relationship between external beam radiotherapy dose and chronic urinary dysfunction--a methodological critiqueTara Rosewall, Charles Catton, Geoffrey Currie, et al.
Pageof 12